2022-05-12 | Verve Therapeutics, Inc. VERV | 20,000 0.0403% | $12.15 | $243,052 | +72.88% | |||
2022-03-15 | Verve Therapeutics, Inc. VERV | 8,000 0.0168% | $21.38 | $171,070 | +5.1% | |||
2021-12-02 | Verve Therapeutics, Inc. VERV | director | 9,400 0.0333% | $31.34 | $294,607 | -15.06% | ||
2007-10-15 | Sale | Biogen Inc. BIIB | EVP, Portfolio Strategy | 60,500 0.0203% | $82.00 | $4.96M | -26.4% | |
2007-08-30 | Sale | Biogen Inc. BIIB | EVP, Portfolio Strategy | 46,000 0.0121% | $49.03 | $2.26M | -3.51% | |
2007-08-27 | Sale | Biogen Inc. BIIB | EVP, Portfolio Strategy | 8,750 0.0021% | $43.50 | $380,625 | -0.92% | |
2007-08-17 | Sale | Biogen Inc. BIIB | EVP, Portfolio Strategy | 28,750 0.01% | $60.46 | $1.74M | +4.15% | |
2007-07-26 | Sale | Biogen Inc. BIIB | EVP, Portfolio Strategy | 115,000 0.0408% | $59.61 | $6.86M | +7.11% | |
2007-07-25 | Sale | Biogen Inc. BIIB | EVP, Portfolio Strategy | 29,000 0.0085% | $50.15 | $1.45M | +5.61% | |
2007-07-03 | Sale | Biogen Inc. BIIB | EVP, Portfolio Strategy | 10,225 0.0029% | $44.24 | $452,354 | +13.13% | |
2007-03-20 | Sale | Biogen Inc. BIIB | EVP, Portfolio Strategy | 6,634 0.0019% | $44.48 | $295,073 | +31.6% | |
2007-02-13 | Sale | Biogen Inc. BIIB | EVP, Portfolio Strategy | 11,871 0.0035% | $49.22 | $584,243 | +15.8% | |
2006-09-19 | Sale | Biogen Inc. BIIB | EVP, Portfolio Strategy | 18,348 0.0054% | $42.75 | $784,329 | +14.13% | |
2006-01-03 | Sale | Biogen Inc. BIIB | EVP, Portfolio Strategy | 57,500 0.0122% | $33.60 | $1.93M | -2.31% | |
2005-12-28 | Sale | Biogen Inc. BIIB | EVP, Portfolio Strategy | 20,500 0.0023% | $16.90 | $346,450 | +0.97% | |
2005-09-28 | Sale | Biogen Inc. BIIB | EVP, Portfolio Strategy | 20,500 0.0061% | $38.39 | $787,086 | +17.35% | |
2005-06-28 | Sale | Biogen Inc. BIIB | EVP, Portfolio Strategy | 20,500 0.0061% | $34.26 | $702,369 | +29.54% | |
2005-01-03 | Sale | Biogen Inc. BIIB | EVP, Portfolio Strategy | 20,500 0.0062% | $67.03 | $1.37M | -40.44% | |
2004-12-27 | Sale | Biogen Inc. BIIB | EVP, Portfolio Strategy | 12,593 0.0006% | $9.67 | $121,774 | -39.77% | |
2004-09-27 | Sale | Biogen Inc. BIIB | EVP, Portfolio Strategy | 12,592 0.0006% | $9.67 | $121,765 | -31.04% |